Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
114.63
-1.25 (-1.07%)
At close: Nov 20, 2026, 4:00 PM EST
115.00
+0.38 (0.33%)
After-hours: Nov 20, 2026, 7:30 PM EST
Incyte Market Cap
Incyte has a market cap or net worth of $23.36 billion as of November 20, 2026. It is the 991st most valuable company in the world and the 419th biggest in the United States. Its market cap has increased by 17.46% in one year.
Market Cap
23.36B
Enterprise Value
19.55B
1-Year Change
17.46%
Global Rank
Country Rank
#419 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Incyte's market cap has increased from $887.90M to $23.36B, an increase of 2,531.41%. That is a compound annual growth rate of 12.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 23.36B | 20.49% |
| Dec 31, 2025 | 19.39B | 45.73% |
| Dec 31, 2024 | 13.31B | -5.44% |
| Dec 29, 2023 | 14.07B | -21.25% |
| Dec 30, 2022 | 17.87B | 10.21% |
| Dec 31, 2021 | 16.21B | -14.88% |
| Dec 31, 2020 | 19.05B | 1.27% |
| Dec 31, 2019 | 18.81B | 38.99% |
| Dec 31, 2018 | 13.53B | -32.29% |
| Dec 29, 2017 | 19.99B | 5.81% |
| Dec 30, 2016 | 18.89B | -6.36% |
| Dec 31, 2015 | 20.17B | 63.32% |
| Dec 31, 2014 | 12.35B | 51.41% |
| Dec 31, 2013 | 8.16B | 274.30% |
| Dec 31, 2012 | 2.18B | 14.96% |
| Dec 30, 2011 | 1.90B | -7.01% |
| Dec 31, 2010 | 2.04B | 88.80% |
| Dec 31, 2009 | 1.08B | 193.21% |
| Dec 31, 2008 | 368.30M | -56.50% |
| Dec 31, 2007 | 846.70M | 72.90% |
| Dec 29, 2006 | 489.70M | 9.92% |
| Dec 30, 2005 | 445.50M | -39.62% |
| Dec 31, 2004 | 737.80M | 48.87% |
| Dec 31, 2003 | 495.60M | 59.97% |
| Dec 31, 2002 | 309.80M | -76.00% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 39.26B |
| Revolution Medicines | 34.87B |
| Genmab | 32.26B |
| Insmed | 31.01B |
| Roivant Sciences | 28.01B |
| BioNTech SE | 20.07B |
| Alnylam Pharmaceuticals | 19.26B |
| Ascendis Pharma | 16.58B |